Tag: Migraine

Dr. Reddy’s Laboratories introduces FDA-approved Nerivio for migraine management in India

businessnewstoday- November 16, 2023

Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced the rollout of Nerivio in India. This state-of-the-art, United States Food and Drug Administration (USFDA) ... Read More

Teva’s AJOVY shows promising results in migraine prevention Phase IV study

businessnewstoday- July 1, 2023

New interim analysis from the pan-European PEARL Phase IV study reveals that Teva Pharmaceutical Industries' AJOVY (fremanezumab) has led to a significant reduction in monthly ... Read More

Zydus Lifesciences subsidiary launches Trokendi XR generic in US

businessnewstoday- January 8, 2023

Zydus Lifesciences (previously Cadila Healthcare) said that its subsidiary Zydus Pharmaceuticals (USA) Inc. has launched Topiramate Extended-Release Capsules in the US. The launch follows the ... Read More

Continental Hospitals opens new headache clinic in Hyderabad

Raghuram Kadari- November 15, 2022

Continental Hospitals has opened Continental Headache Clinic in Hyderabad to provide complete, multi-disciplinary approach for the management and treatment of headache and migraine in both ... Read More

Pfizer to acquire Biohaven in $11.6bn deal to gain access to rimegepant

pallavi123- May 12, 2022

Pfizer has agreed to acquire Biohaven Pharmaceutical, a US-based biopharma company, in a deal worth around $11.6 billion, to gain access to the latter’s dual-acting ... Read More

Dr. Reddy’s Labs to sell certain rights for ELYXYB to BioDelivery Sciences

pallavi123- August 5, 2021

Dr. Reddy's Laboratories (Dr. Reddy's Labs) has agreed to divest its US and Canada rights for migraine drug — ELYXYB (celecoxib oral solution) 25 mg/ml, ... Read More

Novartis reports positive results for Aimovig in phase 2 episodic migraine trial

pharmanewsdaily- October 4, 2020

Novartis said that a five-year phase 2 clinical trial of migraine prevention drug Aimovig (erenumab-aooe) has delivered strong long-term safety and efficacy results in patients ... Read More

Reyvow CENTURION trial results : Lilly migraine drug succeeds in phase 3 study

pharmanewsdaily- September 12, 2020

Reyvow CENTURION trial results : Eli Lilly and Company (Lilly) said that its migraine drug Reyvow (lasmiditan) has met the co-primary endpoint of a phase ... Read More

Cipla gets FDA’s final approval for generic version of Migranal with CGT designation

pharmanewsdaily- May 21, 2020

Cipla has secured final approval for its abbreviated new drug application (ANDA) for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the US Food and Drug Administration ... Read More

Allergan bags Ubrelvy FDA approval for migraine treatment

pharmanewsdaily- December 26, 2019

Ubrelvy FDA approval : Irish pharma company Allergan has bagged approval from the US Food and Drug Administration (FDA) for Ubrelvy (ubrogepant) tablets for the ... Read More